跳至主要内容
临床试验/EUCTR2010-020677-17-DE
EUCTR2010-020677-17-DE进行中(未招募)不适用

Efficacy and safety of xenon anaesthesia compared to sevofluraneanaesthesia and total intravenous anaesthesia for on-pump coronaryartery bypass graft surgery: a randomised, three-arm, single-blind,international study. - Xenon in Cardiac Surgery

Air Liquide Santé International0 个研究点目标入组 509 人开始时间: 2011年6月29日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
509

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1)Male or female patients aged 18 years (or having reached majority if
  • the legal age of majority is over 18) or more at the date of selection
  • 2)Coronary heart disease requiring elective isolated coronary artery
  • bypass graft surgery to be performed with cardiopulmonary bypass in
  • mild hypothermia (central temperature between 32° and 34° Celsius) or
  • normothermia with cardiac arrest and cold or warm cardioplegia
  • 3)Normal or moderately impaired left ventricular systolic function
  • (corresponding to a left ventricular ejection fraction above or equal to
  • 35%, if available)
  • 4)Written informed consent signed and dated by the patient after full
  • explanation of the study has been given by the investigator prior to
  • participation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 412
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 96

排除标准

  • -Legal incapacity or limited legal capacity
  • - Women who are pregnant, breast-feeding or women of childbearing
  • potential not using adequate contraceptive methods
  • - Patient previously randomised in this study
  • - Recent acute myocardial infarction (within 7 days)
  • - Ongoing unstable angina
  • - Active endocarditis
  • - Ongoing treatment with nicorandil
  • - Ongoing treatment with a sulfonylurea medication if this treatment
  • cannot be replaced 24 hours before surgery
  • - Participation in a drug or device trial within the previous 30 days
  • - Known contraindication to xenon, sevoflurane, propofol or sufentanil
  • - Recent or ongoing myocardial damage/infraction with cardiac troponin
  • level assessed within 24 hours of surgery above the upper reference
  • limite for the diagnosis of mycocardial infraction (local laboratory) or
  • prolonged thoracic pain and ST-segement deviation at rest
  • - Severe renal dysfunction with preoperative value of serum creatinine
  • level above 200 micromoles/litre(local laboratory)
  • - Severe haptic dysfunction with preoperative value of alanine aminetransferase
  • or alkaline phosphatase three times above the upper normal
  • value(loval laboratory)
  • - Severely depressed left ventricular function, corresponding to an
  • ejection fraction below 35%,if available

研究者

发起方
Air Liquide Santé International

相似试验